Ligand validation:8DSE

QCT: 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside

QCT is a Ligand Of Interest in 8DSE designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DSE_QCT_B_1103	41%	7%	0.152	0.865	2.21	2.57	12	20	9	0	100%	0.63
8DSE_QCT_A_1005	38%	10%	0.163	0.864	1.73	2.61	9	22	6	0	100%	0.63
8DSH_QCT_B_1502	54%	6%	0.163	0.927	2.35	2.66	14	22	1	0	100%	1
4GUE_QCT_A_401	92%	12%	0.068	0.96	2.72	1.39	8	9	0	0	100%	1
8EQ5_QCT_A_401	92%	49%	0.068	0.957	0.85	1.1	1	4	0	0	100%	1
5A4W_QCT_D_1213	66%	23%	0.123	0.928	1.41	1.73	7	13	0	0	100%	1
8R58_QCT_A_401	61%	57%	0.112	0.901	0.67	0.99	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.